Medical Tech Stock Jumps on FDA Ruling: Sean Mason’s Canadian Small Cap Market Movers

Sean Mason | October
19, 2015 | SmallCapPower

A small
medical technology play generated some healthy gains following a FDA decision
Monday, while a resource junior moved up on financing news. Here’s some small
stocks making big moves on Monday, October 19, 2015 (as of 4 pm EST):

MedMira Inc. (TSXV:
) shares powered 100% higher to $0.07 on volume of more than 5.6 million
shares Monday after the medical device maker announced that it has received
approval from the U.S. Food and Drug Administration (FDA) for the next
generation of the Company’s rapid HIV test, Reveal G4 Rapid HIV-1 Antibody Test.
Reveal G4 adds new capabilities in testing fingerstick and venipuncture whole
blood specimens, which extends the Reveal product line into point-of-care
settings and new market segments within the U.S. healthcare market.

As well,
shares of Cyprium Mining Corporation (TSXV:
) rose as much as 15% before ending unchanged at $0.10 as the resource project developer said that following
theannouncement on the proposed
joint venture for the exploitation and exploration of the Potosi silver mine in
Mexico, the company was approached by investors wanting to participate in its
future growth by way of equity as opposed to financing using bonds.

CardioComm Solutions, Inc. (TSXV:
) stock price, meanwhile, moved up 38% to $0.055 after a positive media
that suggested, among other things, that the Company’s HeartCheck
Pen was generating much interest in developing countries where doctors can’t
afford $3,000 ECG machines.

More from Sean Mason

Hi, did you know SmallCapPower
accepts blog submissions? You can contact me at